Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug
Shares of Zydus Lifesciences hit a 52-week high in morning trade on April 19 after the company said it had received final approval from the...
Use UNICORN Signals App
By EquityPandit
